Analysis of uncertainty in the economic assessment of health interventions;Análisis de la incertidumbre en las evaluaciones económicas de intervenciones sanitarias

Medicina Clinica

Volumn 122, Issue 17, 2004, Pages 668-674

  Rubio Terrés, Carlos ^a   Cobo, Erik ^b   Sacristán, José Antonio ^c,f   Prieto, Luis ^c   Del Llano, Juan ^d   Badia, Xavier ^e  

^a HERO Consulting   (Spain)

^b UNIVERSITAT POLITÈCNICA DE CATALUNYA   (Spain)

^c Lilly SA Alcobendas   (Spain)

^d Fundacion Gaspar Casal   (Spain)

^e Health Outcomes Research Europe   (Spain)

^f ELI LILLY AND COMPANY   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; FINANCIAL MANAGEMENT; HEALTH CARE; HEALTH SERVICE; REVIEW; RISK ASSESSMENT;

EID: 2942511453     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13061390     Document Type: Review

References (27)

1. Economics and Development Resource Center. Sensitivity analysis. En: Handbook for the economic analysis of health sector projects. Philippines: Asian Development Bank, August 2000. Disponible en: http://www.adb.org/Documents/Handbooks/Health_Sector_Projects/Chap_07.pdf
2. Paté-Cornell E. Risk and uncertainty analysis in governement safety decisions [consultado 06/2003]. Disponible en: http://www.ce.ncsu. edu/risk/pdf/pate.pdf.
3. Koelle HH. Sensitivity analysis of assumptions determining size and cost of lunar base installations. IRL Mitt. 354 (2001) (7.7.2001). Technical University of Berlin. Institute of Aeronautics and Astronautics. Disponible en: http://vulcain.fb12.tu-berlin.de/Raumfahzeugtechnic/IRL-Mitteilungen/Archive/ IRL354.pdf.
4. Briggs AH, Gray AM. Handling uncertainty when performing economic evaluation of healthcare interventions. Health Technol Assess 1999;3:1-134.
5. Manning WG, Fryback DG, Weinstein MC. Reflecting uncertainty in cost-effectiveness analysis. En: Gold MR, Siegel JE, Russell LB, Weinstein MC, editors. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996; p. 247-75.
6. Briggs AH. Handling uncertainty in economic evaluation and presenting the results. En: Drummond M, McGuire A, editors. Economic evaluation in health care. Merging theory with practice. New York Oxford University Press, 2001; p. 172-213.
7. Kielhorn A, Graf von der Schulenburg JM. The health economics handbook. Chowley Oak Lane: Adis International, 2000.
8. Briggs A, Sculpher M. Sensitivity analysis in economic evaluation: a review of published studies. Health Econ 1995;4:355-71.
9. Prieto L, Sacristán JA, Antoñanzas F, Rubio-Terrés C, Pinto JL, Rovira J, por el grupo ECOMED. Análisis coste-efectividad en la evaluación económica de intervenciones sanitarias. Med Clin (Barc) 2004;122:505-10.
10. Peis F. Aspectos estadísticos en el diseño, elaboración y análisis en los estudios de farmacoeconomía e investigación de resultados en salud. En: Domínguez-Gil A, Soto J, coordinadores. Farmacoeconomía e investigación de resultados en la salud: principios y práctica. Situación actual y perspectivas futuras en España. Madrid: Real Academia Nacional de Farmacia, 2002; p. 337-58.
11. O'Brien BJ, Drummond MF, Labelle RJ, William A. In search of power and significance: issues in the design and analysis of stochastic cost-effectiveness studies in healthcare. Med Care 1994;32:150-63.
12. Van Hout BA, Al MJ, Gordon GS, Rutten FF. Costs, effects and C/E-ratios alongside a clinical trial. Health Econ 1994;3:309-19.
13. Briggs A, Fenn P. Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane. Health Econ 1998;7:723-40.
14. Sacristán JA, Day SJ, Navarro O, Ramos J, Hernández JM. Use of confidence intervals and sample size calculations in health economic studies. Ann Pharmacother 1995;29:719-25.
15. Glick HA, Briggs AH, Polsky D. Quantifying stochastic uncertainty and presenting results of cost-effectiveness analyses. Expert Rev Pharmacoeconomics Outcomes Res 2001;1:89-100.
16. Howell DC. Resampling statistics: randomization and the boostrap. University of Vermont. Disponible en: http://www.uvm.edu/~dhowell/StatPages/Resampling/Resampling.html
17. Carpenter J, Bithell J. Bootstrap confidence intervals: when, which, what? A practice guide for medical statisticians. Statist Med 2000;19:1141-1164.
18. Heyse JF, Cook JR, Carides GW. Statistical considerations in analysis health care resource utilization and cost data. En: Drummond M, McGuire A, editors. Economic evaluation in health care. Merging theory with practice. New York: Oxford University Press, 2001; p. 172-213.
19. Critchfield GC, Willard KE. Probabilistic analysis of decision trees using Monte Carlo simulation. Med Decis Making 1986;6:85-92.
20. Doubilet P, Begg CB, Weinstein MC, Braun P, McNeil BJ. Probabilistic sensitivity analysis using Monte Carlo simulation. Med Decis Making 1985;5:157-77.
21. Agro KE, Bradley CA, Mittmann N, Iskedjian M, Ilersich AL, Einarson TR. Sensitivity analysis in health economic and pharmacoeconomic studies. An appraisal of the literature. Pharmacoeconomics 1997;11:75-88.
22. Briggs AH, Gray AM. Handling uncertainty in economic evaluations of healthcare interventions. BMJ 1999;319:635-8.
23. Polsky D, Glick HA, Wilke R, Schulman K. Confidence intervals for cost-effectiveness ratios: a comparison of four methods. Health Econ 1997;7:243-52.
24. Stinnett AA, Mullahy J. Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis. Med Decis Making 1998;18(Suppl):68-80.
25. Obenchain RL, Sacristán JA. The negative side of cost-effectiveness analysis (carta). JAMA 1997;277:1932.
26. Eddy DM, Hasselblad V, Schachter RD. Meta-analysis by the confidence profile method: the statistical synthesis of evidence. Boston: Academic Press, 1992.
27. Spiegehalter DJ, Myles JP, Jones DR, Abrams KR. Methods in health service research: an introduction to Bayesian methods in health technology assessment. BMJ 1999;319:508-12.